Trial Profile
Cotrimoxazole +/- albendazole + praziquantel in patients with HIV-1 infections
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Mar 2012
Price :
$35
*
At a glance
- Drugs Albendazole (Primary) ; Cotrimoxazole (Primary) ; Praziquantel (Primary)
- Indications Helminthiasis; HIV-1 infections; Schistosomiasis
- Focus Therapeutic Use
- 19 Mar 2012 New trial record
- 08 Mar 2012 Results presented at the 19th Conference on Retroviruses and Opportunistic Infections.